Single-cell multi-omics analysis of the immune response in COVID-19
Analysis of human blood immune cells provides insights into the coordinated response to viral infections such as severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19). We performed single-cell transcriptome, surface proteome and T and B lymphocyte antigen receptor analyses of over 780,000 peripheral blood mononuclear cells from a cross-sectional cohort of 130 patients with varying severities of COVID-19. We identified expansion of nonclassical monocytes expressing complement transcripts (CD16+C1QA/B/C+) that sequester platelets and were predicted to replenish the alveolar macrophage pool in COVID-19. Early, uncommitted CD34+ hematopoietic stem/progenitor cells were primed toward megakaryopoiesis, accompanied by expanded megakaryocyte-committed progenitors and increased platelet activation. Clonally expanded CD8+ T cells and an increased ratio of CD8+ effector T cells to effector memory T cells characterized severe disease, while circulating follicular helper T cells accompanied mild disease. We observed a relative loss of IgA2 in symptomatic disease despite an overall expansion of plasmablasts and plasma cells. Our study highlights the coordinated immune response that contributes to COVID-19 pathogenesis and reveals discrete cellular components that can be targeted for therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
Nature medicine - 27(2021), 5 vom: 15. Mai, Seite 904-916 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Stephenson, Emily [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 24.05.2021 Date Revised 27.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41591-021-01329-2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM324342802 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM324342802 | ||
003 | DE-627 | ||
005 | 20240327235017.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41591-021-01329-2 |2 doi | |
028 | 5 | 2 | |a pubmed24n1350.xml |
035 | |a (DE-627)NLM324342802 | ||
035 | |a (NLM)33879890 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Stephenson, Emily |e verfasserin |4 aut | |
245 | 1 | 0 | |a Single-cell multi-omics analysis of the immune response in COVID-19 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.05.2021 | ||
500 | |a Date Revised 27.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Analysis of human blood immune cells provides insights into the coordinated response to viral infections such as severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19). We performed single-cell transcriptome, surface proteome and T and B lymphocyte antigen receptor analyses of over 780,000 peripheral blood mononuclear cells from a cross-sectional cohort of 130 patients with varying severities of COVID-19. We identified expansion of nonclassical monocytes expressing complement transcripts (CD16+C1QA/B/C+) that sequester platelets and were predicted to replenish the alveolar macrophage pool in COVID-19. Early, uncommitted CD34+ hematopoietic stem/progenitor cells were primed toward megakaryopoiesis, accompanied by expanded megakaryocyte-committed progenitors and increased platelet activation. Clonally expanded CD8+ T cells and an increased ratio of CD8+ effector T cells to effector memory T cells characterized severe disease, while circulating follicular helper T cells accompanied mild disease. We observed a relative loss of IgA2 in symptomatic disease despite an overall expansion of plasmablasts and plasma cells. Our study highlights the coordinated immune response that contributes to COVID-19 pathogenesis and reveals discrete cellular components that can be targeted for therapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Proteome |2 NLM | |
650 | 7 | |a Receptors, Antigen, B-Cell |2 NLM | |
650 | 7 | |a Receptors, Antigen, T-Cell |2 NLM | |
700 | 1 | |a Reynolds, Gary |e verfasserin |4 aut | |
700 | 1 | |a Botting, Rachel A |e verfasserin |4 aut | |
700 | 1 | |a Calero-Nieto, Fernando J |e verfasserin |4 aut | |
700 | 1 | |a Morgan, Michael D |e verfasserin |4 aut | |
700 | 1 | |a Tuong, Zewen Kelvin |e verfasserin |4 aut | |
700 | 1 | |a Bach, Karsten |e verfasserin |4 aut | |
700 | 1 | |a Sungnak, Waradon |e verfasserin |4 aut | |
700 | 1 | |a Worlock, Kaylee B |e verfasserin |4 aut | |
700 | 1 | |a Yoshida, Masahiro |e verfasserin |4 aut | |
700 | 1 | |a Kumasaka, Natsuhiko |e verfasserin |4 aut | |
700 | 1 | |a Kania, Katarzyna |e verfasserin |4 aut | |
700 | 1 | |a Engelbert, Justin |e verfasserin |4 aut | |
700 | 1 | |a Olabi, Bayanne |e verfasserin |4 aut | |
700 | 1 | |a Spegarova, Jarmila Stremenova |e verfasserin |4 aut | |
700 | 1 | |a Wilson, Nicola K |e verfasserin |4 aut | |
700 | 1 | |a Mende, Nicole |e verfasserin |4 aut | |
700 | 1 | |a Jardine, Laura |e verfasserin |4 aut | |
700 | 1 | |a Gardner, Louis C S |e verfasserin |4 aut | |
700 | 1 | |a Goh, Issac |e verfasserin |4 aut | |
700 | 1 | |a Horsfall, Dave |e verfasserin |4 aut | |
700 | 1 | |a McGrath, Jim |e verfasserin |4 aut | |
700 | 1 | |a Webb, Simone |e verfasserin |4 aut | |
700 | 1 | |a Mather, Michael W |e verfasserin |4 aut | |
700 | 1 | |a Lindeboom, Rik G H |e verfasserin |4 aut | |
700 | 1 | |a Dann, Emma |e verfasserin |4 aut | |
700 | 1 | |a Huang, Ni |e verfasserin |4 aut | |
700 | 1 | |a Polanski, Krzysztof |e verfasserin |4 aut | |
700 | 1 | |a Prigmore, Elena |e verfasserin |4 aut | |
700 | 1 | |a Gothe, Florian |e verfasserin |4 aut | |
700 | 1 | |a Scott, Jonathan |e verfasserin |4 aut | |
700 | 1 | |a Payne, Rebecca P |e verfasserin |4 aut | |
700 | 1 | |a Baker, Kenneth F |e verfasserin |4 aut | |
700 | 1 | |a Hanrath, Aidan T |e verfasserin |4 aut | |
700 | 1 | |a Schim van der Loeff, Ina C D |e verfasserin |4 aut | |
700 | 1 | |a Barr, Andrew S |e verfasserin |4 aut | |
700 | 1 | |a Sanchez-Gonzalez, Amada |e verfasserin |4 aut | |
700 | 1 | |a Bergamaschi, Laura |e verfasserin |4 aut | |
700 | 1 | |a Mescia, Federica |e verfasserin |4 aut | |
700 | 1 | |a Barnes, Josephine L |e verfasserin |4 aut | |
700 | 1 | |a Kilich, Eliz |e verfasserin |4 aut | |
700 | 1 | |a de Wilton, Angus |e verfasserin |4 aut | |
700 | 1 | |a Saigal, Anita |e verfasserin |4 aut | |
700 | 1 | |a Saleh, Aarash |e verfasserin |4 aut | |
700 | 1 | |a Janes, Sam M |e verfasserin |4 aut | |
700 | 1 | |a Smith, Claire M |e verfasserin |4 aut | |
700 | 1 | |a Gopee, Nusayhah |e verfasserin |4 aut | |
700 | 1 | |a Wilson, Caroline |e verfasserin |4 aut | |
700 | 1 | |a Coupland, Paul |e verfasserin |4 aut | |
700 | 1 | |a Coxhead, Jonathan M |e verfasserin |4 aut | |
700 | 1 | |a Kiselev, Vladimir Yu |e verfasserin |4 aut | |
700 | 1 | |a van Dongen, Stijn |e verfasserin |4 aut | |
700 | 1 | |a Bacardit, Jaume |e verfasserin |4 aut | |
700 | 1 | |a King, Hamish W |e verfasserin |4 aut | |
700 | 0 | |a Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID-19 BioResource Collaboration |e verfasserin |4 aut | |
700 | 1 | |a Rostron, Anthony J |e verfasserin |4 aut | |
700 | 1 | |a Simpson, A John |e verfasserin |4 aut | |
700 | 1 | |a Hambleton, Sophie |e verfasserin |4 aut | |
700 | 1 | |a Laurenti, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Lyons, Paul A |e verfasserin |4 aut | |
700 | 1 | |a Meyer, Kerstin B |e verfasserin |4 aut | |
700 | 1 | |a Nikolić, Marko Z |e verfasserin |4 aut | |
700 | 1 | |a Duncan, Christopher J A |e verfasserin |4 aut | |
700 | 1 | |a Smith, Kenneth G C |e verfasserin |4 aut | |
700 | 1 | |a Teichmann, Sarah A |e verfasserin |4 aut | |
700 | 1 | |a Clatworthy, Menna R |e verfasserin |4 aut | |
700 | 1 | |a Marioni, John C |e verfasserin |4 aut | |
700 | 1 | |a Göttgens, Berthold |e verfasserin |4 aut | |
700 | 1 | |a Haniffa, Muzlifah |e verfasserin |4 aut | |
700 | 1 | |a Baker, Stephen |e investigator |4 oth | |
700 | 1 | |a Bradley, John R |e investigator |4 oth | |
700 | 1 | |a Dougan, Gordon |e investigator |4 oth | |
700 | 1 | |a Goodfellow, Ian G |e investigator |4 oth | |
700 | 1 | |a Gupta, Ravindra K |e investigator |4 oth | |
700 | 1 | |a Hess, Christoph |e investigator |4 oth | |
700 | 1 | |a Kingston, Nathalie |e investigator |4 oth | |
700 | 1 | |a Lehner, Paul J |e investigator |4 oth | |
700 | 1 | |a Matheson, Nicholas J |e investigator |4 oth | |
700 | 1 | |a Owehand, Willem H |e investigator |4 oth | |
700 | 1 | |a Saunders, Caroline |e investigator |4 oth | |
700 | 1 | |a Smith, Kenneth G C |e investigator |4 oth | |
700 | 1 | |a Summers, Charlotte |e investigator |4 oth | |
700 | 1 | |a Thaventhiran, James E D |e investigator |4 oth | |
700 | 1 | |a Toshner, Mark |e investigator |4 oth | |
700 | 1 | |a Weekes, Michael P |e investigator |4 oth | |
700 | 1 | |a Bucke, Ashlea |e investigator |4 oth | |
700 | 1 | |a Calder, Jo |e investigator |4 oth | |
700 | 1 | |a Canna, Laura |e investigator |4 oth | |
700 | 1 | |a Domingo, Jason |e investigator |4 oth | |
700 | 1 | |a Elmer, Anne |e investigator |4 oth | |
700 | 1 | |a Fuller, Stewart |e investigator |4 oth | |
700 | 1 | |a Harris, Julie |e investigator |4 oth | |
700 | 1 | |a Hewitt, Sarah |e investigator |4 oth | |
700 | 1 | |a Kennet, Jane |e investigator |4 oth | |
700 | 1 | |a Jose, Sherly |e investigator |4 oth | |
700 | 1 | |a Kourampa, Jenny |e investigator |4 oth | |
700 | 1 | |a Meadows, Anne |e investigator |4 oth | |
700 | 1 | |a O'Brien, Criona |e investigator |4 oth | |
700 | 1 | |a Price, Jane |e investigator |4 oth | |
700 | 1 | |a Publico, Cherry |e investigator |4 oth | |
700 | 1 | |a Rastall, Rebecca |e investigator |4 oth | |
700 | 1 | |a Ribeiro, Carla |e investigator |4 oth | |
700 | 1 | |a Rowlands, Jane |e investigator |4 oth | |
700 | 1 | |a Ruffolo, Valentina |e investigator |4 oth | |
700 | 1 | |a Tordesillas, Hugo |e investigator |4 oth | |
700 | 1 | |a Bullman, Ben |e investigator |4 oth | |
700 | 1 | |a Dunmore, Benjamin J |e investigator |4 oth | |
700 | 1 | |a Fawke, Stuart |e investigator |4 oth | |
700 | 1 | |a Gräf, Stefan |e investigator |4 oth | |
700 | 1 | |a Hodgson, Josh |e investigator |4 oth | |
700 | 1 | |a Huang, Christopher |e investigator |4 oth | |
700 | 1 | |a Hunter, Kelvin |e investigator |4 oth | |
700 | 1 | |a Jones, Emma |e investigator |4 oth | |
700 | 1 | |a Legchenko, Ekaterina |e investigator |4 oth | |
700 | 1 | |a Matara, Cecilia |e investigator |4 oth | |
700 | 1 | |a Martin, Jennifer |e investigator |4 oth | |
700 | 1 | |a O'Donnell, Ciara |e investigator |4 oth | |
700 | 1 | |a Pointon, Linda |e investigator |4 oth | |
700 | 1 | |a Pond, Nicole |e investigator |4 oth | |
700 | 1 | |a Shih, Joy |e investigator |4 oth | |
700 | 1 | |a Sutcliffe, Rachel |e investigator |4 oth | |
700 | 1 | |a Tilly, Tobias |e investigator |4 oth | |
700 | 1 | |a Treacy, Carmen |e investigator |4 oth | |
700 | 1 | |a Tong, Zhen |e investigator |4 oth | |
700 | 1 | |a Wood, Jennifer |e investigator |4 oth | |
700 | 1 | |a Wylot, Marta |e investigator |4 oth | |
700 | 1 | |a Betancourt, Ariana |e investigator |4 oth | |
700 | 1 | |a Bower, Georgie |e investigator |4 oth | |
700 | 1 | |a De Sa, Aloka |e investigator |4 oth | |
700 | 1 | |a Epping, Madeline |e investigator |4 oth | |
700 | 1 | |a Huhn, Oisin |e investigator |4 oth | |
700 | 1 | |a Jackson, Sarah |e investigator |4 oth | |
700 | 1 | |a Jarvis, Isobel |e investigator |4 oth | |
700 | 1 | |a Marsden, Jimmy |e investigator |4 oth | |
700 | 1 | |a Nice, Francesca |e investigator |4 oth | |
700 | 1 | |a Okecha, Georgina |e investigator |4 oth | |
700 | 1 | |a Omarjee, Ommar |e investigator |4 oth | |
700 | 1 | |a Perera, Marianne |e investigator |4 oth | |
700 | 1 | |a Richoz, Nathan |e investigator |4 oth | |
700 | 1 | |a Sharma, Rahul |e investigator |4 oth | |
700 | 1 | |a Turner, Lori |e investigator |4 oth | |
700 | 1 | |a De Bie, Eckart M D D |e investigator |4 oth | |
700 | 1 | |a Bunclark, Katherine |e investigator |4 oth | |
700 | 1 | |a Josipovic, Masa |e investigator |4 oth | |
700 | 1 | |a Mackay, Michael |e investigator |4 oth | |
700 | 1 | |a Michael, Alice |e investigator |4 oth | |
700 | 1 | |a Rossi, Sabrina |e investigator |4 oth | |
700 | 1 | |a Selvan, Mayurun |e investigator |4 oth | |
700 | 1 | |a Spencer, Sarah |e investigator |4 oth | |
700 | 1 | |a Yong, Cissy |e investigator |4 oth | |
700 | 1 | |a Ansaripour, Ali |e investigator |4 oth | |
700 | 1 | |a Mwaura, Lucy |e investigator |4 oth | |
700 | 1 | |a Patterson, Caroline |e investigator |4 oth | |
700 | 1 | |a Polwarth, Gary |e investigator |4 oth | |
700 | 1 | |a Polgarova, Petra |e investigator |4 oth | |
700 | 1 | |a Stefano, Giovanni di |e investigator |4 oth | |
700 | 1 | |a Allison, John |e investigator |4 oth | |
700 | 1 | |a Butcher, Helen |e investigator |4 oth | |
700 | 1 | |a Caputo, Daniela |e investigator |4 oth | |
700 | 1 | |a Clapham-Riley, Debbie |e investigator |4 oth | |
700 | 1 | |a Dewhurst, Eleanor |e investigator |4 oth | |
700 | 1 | |a Furlong, Anita |e investigator |4 oth | |
700 | 1 | |a Graves, Barbara |e investigator |4 oth | |
700 | 1 | |a Gray, Jennifer |e investigator |4 oth | |
700 | 1 | |a Ivers, Tasmin |e investigator |4 oth | |
700 | 1 | |a Kasanicki, Mary |e investigator |4 oth | |
700 | 1 | |a Gresley, Emma Le |e investigator |4 oth | |
700 | 1 | |a Linger, Rachel |e investigator |4 oth | |
700 | 1 | |a Meloy, Sarah |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Nature medicine |d 1995 |g 27(2021), 5 vom: 15. Mai, Seite 904-916 |w (DE-627)NLM074659804 |x 1546-170X |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2021 |g number:5 |g day:15 |g month:05 |g pages:904-916 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41591-021-01329-2 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 27 |j 2021 |e 5 |b 15 |c 05 |h 904-916 |